Top of this page
Skip navigation, go straight to the content
UCB is a global biopharmaceutical company focused on creating value for people living with severe diseases in immunology and neurology.
We work with stakeholders to address the unmet needs of patients and caregivers, helping them to achieve their goals and to live the lives they want. UCB is on a journey to become the patient-preferred biopharma leader by delivering medicines and solutions that improve lives. Our commitment to value is a promise to bring together the talent, expertise, tools and scientific know-how required to serve patients in need.
At UCB, we take our responsibility
to the planet very seriously.
UCB Ventures, our strategic corporate venture fund established in 2017
Twitter Feed
-
“UCB is an exciting, innovative and dynamic workplace with a clear focus on improving patients life: being part this adventure is fascinating and very rewarding.” Gael, Scientist https://t.co/PO5ov64w2w
— UCB News (@ucb_news) 19.07.2019 -
@highburygrove Thank you for sending your feedback. We are aware of the situation and are looking to improve the sustainability of our packaging moving forward. To learn more about our new approach to packaging, please visit https://t.co/flNt1JCSXi
— UCB News (@ucb_news) 18.07.2019 -
"Working at UCB is a fantastic opportunity to learn and develop yourself while contributing to develop better solutions for patients." - Lauriane, Scientist https://t.co/HZhE6Z9CLs
— UCB News (@ucb_news) 17.07.2019
